HPV vaccine uptake in men who have sex with men in Scotland
| Autor: | S. Wrigglesworth, L.A. Wallace, Kevin G.J. Pollock, D. McMaster, N. Steedman |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male medicine.medical_specialty Sexual health clinic Adolescent Sexual Behavior media_common.quotation_subject 030231 tropical medicine Disease Men who have sex with men Young Adult 03 medical and health sciences 0302 clinical medicine Age groups Humans Medicine Public Health Surveillance Papillomavirus Vaccines 030212 general & internal medicine Homosexuality Homosexuality Male Human papillomavirus Reproductive health media_common General Veterinary General Immunology and Microbiology Immunization Programs business.industry Papillomavirus Infections Vaccination Public Health Environmental and Occupational Health virus diseases Middle Aged medicine.disease Infectious Diseases Scotland Family medicine Molecular Medicine business |
| Zdroj: | Vaccine. 37:5513-5514 |
| ISSN: | 0264-410X |
| DOI: | 10.1016/j.vaccine.2018.11.081 |
| Popis: | Human papillomavirus (HPV) vaccines are currently utilised globally in national immunisation programmes. In July 2017, a national HPV vaccine programme for men who have sex with men (MSM) was initiated across Scotland with vaccine being offered in the sexual health clinic setting. During the first year of this targeted vaccination programme, there were 5905 individuals who received at least one dose of HPV vaccine, representing 63.7% of eligible MSM attendees in this period. Vaccine uptake was relatively stable across all age groups (range 49.8-55.5%). The vaccination programme appears to have dovetailed well with pre-existing sexual health services and appears to be popular with MSM attending the service. The MSM HPV vaccine programme is a robust adjunct to the national girls programme but gender-neutral immunisation will reduce stigma and inequality in HPV-driven disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect